Zheng Song
State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine/Department Of Lymphoma, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma.
Journal: Frontiers in immunology
Published: January 18, 2026
Single-cell and bulk transcriptomics reveal a CD8+ T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma.
Journal: Frontiers in immunology
Published: August 14, 2025
Correction: Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study.
Journal: Frontiers in immunology
Published: June 16, 2025
Clinical Features and Outcomes of Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified, Treated with CHOP-Based Regimens.
Journal: Cancers
Published: April 08, 2025
A Novel Prognostic Score for Disease Progression and Mortality in Patients With Newly Diagnosed Primary Large B-Cell Lymphoma of Immune-Privileged Sites.
Journal: Hematological oncology
Published: March 03, 2025
Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study.
Journal: Frontiers in immunology
Published: February 19, 2025
Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim 18F-FDG PET-CT Analysis and the NCCN-IPI: A Multicenter Retrospective Study.
Journal: Hematological oncology
Published: January 09, 2025
An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma.
Journal: Expert opinion on biological therapy
Published: December 20, 2024
Adverse events in the nervous system associated with blinatumomab: a real-world study.
Journal: BMC medicine
Published: October 20, 2024
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 23, 2024
Last Updated: 09/26/2026